B.U Technology Logo

B.U Technology

Commercializes university research via IP management, licensing, and new venture creation.

230980 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
부산광역시 강서구 명지국제2로28번길 34 에코팰리스 318호, 부산광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Boston University's Office of Technology Development (OTD) facilitates the commercialization of inventions and discoveries emerging from the university's research community. The office's primary objective is to translate groundbreaking research into market-ready applications by fostering collaborations between BU inventors and the entrepreneurial and industrial ecosystems. Key services include intellectual property management, patenting, technology licensing, and providing comprehensive support for the formation of new ventures. The OTD also connects industry partners with university researchers and offers education, tools, and mentorship to faculty, students, and alumni across sectors including life sciences, medical technology, and engineering.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for B.U Technology and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-19 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 12.5 KB

Automate Your Workflow. Get a real-time feed of all B.U Technology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for B.U Technology via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.